Education
About Us
Working with TipRanks
Follow Us
Amplia Therapeutics Ltd. (AU:ATX)
:ATX
Narmafotinib Ascending Doses, Narmafotinib Dose Comparison
Pancreatic Cancer Metastatic
Phase I/II
Recruiting
A Study of Narmafotinib Given in Combination With Modified FOLFIRINOX in Patients With Metastatic Pancreatic Cancer
Apr 29, 2025
―
Amp945 Ascending Doses, Amp945 Rp2d
Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Pdac
Phase I/II
Active Not Recruiting
ACCENT: AMP945 in Combination with Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer
Apr 07, 2022
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Amplia Therapeutics Ltd. (ATX) have in its pipeline
ATX is currently developing the following drugs: Narmafotinib Ascending Doses, Narmafotinib Dose Comparison, Amp945 Ascending Doses, Amp945 Rp2d. These drug candidates are in various stages of clinical development as the company works toward FDA approval.